|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Current assets | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Prepaid expenses | ||||||||||||||||||||
| Other receivables | ||||||||||||||||||||
| Other current assets | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Property and equipment, net | ||||||||||||||||||||
| Deposits | ||||||||||||||||||||
| Operating lease right-of-use assets | ||||||||||||||||||||
| Finance lease right-of-use asset | ||||||||||||||||||||
| Other non-current assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Liabilities and stockholders’ equity (deficit) | ||||||||||||||||||||
| Current liabilities | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Accrued expenses | ||||||||||||||||||||
| Royalties payable | ||||||||||||||||||||
| Deferred grant funding | ||||||||||||||||||||
| Deferred revenue | ||||||||||||||||||||
| Current portion of liability related to the sale of future royalties | ||||||||||||||||||||
| Current portion of lease liabilities, operating | ||||||||||||||||||||
| Current portion of lease liability, finance | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Deferred revenue, non-current | ||||||||||||||||||||
| Liability related to the sale of future royalties, net | ||||||||||||||||||||
| Lease liabilities long-term, operating | ||||||||||||||||||||
| Lease liability long-term, finance | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Stockholders' (deficit) equity | ||||||||||||||||||||
| Preferred stock, $0.01 par value, 5,000,000 shares authorized; 4,999,620 and 0 designated Series A Convertible Preferred Stock at June 30, 2026 and December 31, 2025, respectively; 75,900 and 0 issued and outstanding at June 30, 2026 and December 31, 2025, respectively. Liquidation preference of $0.4 million and $0 at June 30, 2026 and December 31, 2025, respectively | ||||||||||||||||||||
| Common stock, $0.0001 par value; 240,000,000 shares authorized; 15,169,502 and 14,499,502 shares issued and outstanding at June 30, 2026 and December 31, 2025, respectively | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Accumulated other comprehensive loss | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Total stockholders' (deficit) equity | ||||||||||||||||||||
| Total liabilities and stockholders' (deficit) equity | ||||||||||||||||||||
| Common stock, shares authorized (in shares) | ||||||||||||||||||||
Loading...
